A robust specialty drug pipeline and resulting changes in pharmacy benefits for specialty products, in addition to the new innovative pharmacy clinical services programs, are among some of the greatest opportunities for PBMs and health plans. The event will cover topics including ePrior authorization, generic drugs, biosimilars, restrictive formularies and more.